Dr Rinat Bernstein Molho Kangker payudara

Dr Rinat Bernstein-Molho lulus ti Institut Téknologi Israél Sakola Médis di Haifa di 2004. Manehna réngsé karésidénan di Onkologi Médis lajeng hiji karésidénan tambahan dina Médis Genetika di Tel Aviv Médis Center. Anjeunna ngurus klinik oncogenetic di Pusat Médis Tel Aviv.

She joined Kangker payudara institute in the Sheba Medical Center at Tel Hashomer in 2017, where she works as a medical oncologist and clinical cancer geneticist. Her area of clinical and research interest is hereditary cancers.

Atikan sarta Latihan

• Dr Rinat Bernstein Molho lulus kalawan honors ti Fakultas Kedokteran di Technion University, Haifa.
• Anjeunna teras khusus dina Onkologi di Departemen Onkologi, Pusat Médis Tel Aviv.
• Anjeunna ogé khusus dina Genetika di Institute of Genetics, Tel Aviv Medical Center.

Publications

Akurasi Modél Prediksi Résiko pikeun Kangker Payudara sareng Probabilitas Pembawa Mutasi BRCA1 / BRCA2 di Israél. Kenan ES, Friger M, Shochat-Bigon D, Schayek H, Bernstein-Molho R, Friedman E.

Ngahasilkeun genotyping BRCA1 / 2 pinuh dina pasien kanker payudara / ovarium résiko luhur Israél anu henteu mawa mutasi utama. Barnes-Kedar I, Bernstein-Molho R, Ginzach N, Hartmajer S, Shapira T, Magal N, Kalis ML, Peretz T, Shohat M, Basel-Salmon L, Friedman E, Bazak L, Goldberg Y.

Evaluasi tolerability na efficacy of incorporating carboplatin di anthracycline neoadjuvant jeung terapi dumasar taxane dina BRCA1 enriched triple-négatip cohort kanker payudara. Sella T, Gal Yam EN, Levanon K, Rotenberg TS, Gadot M, Kuchuk I, Molho rb, Itai A, Modiano TM, emas R, Kaufman B, Shimon SP.

Kangker payudara